591
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Comparison of several commonly used detection indicators of cell senescence

, & ORCID Icon
Pages 213-218 | Received 06 Sep 2018, Accepted 13 Nov 2018, Published online: 27 Dec 2018

References

  • Aird, K.M., et al., 2016. HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci. The Journal of Cell Biology, 215 (3), 325–334.
  • Aird, K.M., and Zhang, R., 2013. Detection of senescence-associated heterochromatin foci (SAHF). Methods in Molecular Biology (Clifton, N.J.), 965 (2), 185–196.
  • Arun, P., et al., 2011. Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization. Plos One, 6 (2), e16545
  • Baker, D.J., et al., 2011. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature, 479 (7372), 232–236.
  • Bernadotte, A., Mikhelson, V.M., and Spivak, I.M., 2016. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging, 8 (1), 3–11.
  • Blasco, M.A., 2005. Telomeres and human disease: ageing, cancer and beyond. Nature reviews. Genetics, 6 (8), 611–622.
  • Brain, J.G., et al., 2013. Biliary epithelial senescence and plasticity in acute cellular rejection. American Journal of Transplantation, 13 (7), 1688–1702.
  • Burd, C.E., et al., 2013. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell, 152 (1–2), 340–351.
  • Burton, D.G., and Krizhanovsky, V., 2014. Physiological and pathological consequences of cellular senescence. Cellular and Molecular Life Sciences, 71 (22), 4373–4386.
  • Campisi, J., 2013. Aging, cellular senescence, and cancer. Annual Review of Physiology, 75, 685–705.
  • Campisi, J., and Fagagna, F., 2007. Cellular senescence: when bad things happen to good cells. Nature Reviews. Molecular Cell Biology, 8 (9), 729–740.
  • Chakraborty, S., et al., 2016. Cristacarpin promotes ER stress-mediated ROS generation leading to premature senescence by activation of p21 waf-1. Age, 38 (3), 1–14.
  • Chen, W., et al., 2008. p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts. International Journal of Molecular Medicine, 21 (5), 645–653.
  • Cristofalo, V.J., 2005. SA beta Gal staining: biomarker or delusion. Experimental Gerontology, 40 (10), 836–838.
  • Dimri, G.P., et al., 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America, 92 (20), 9363–9367.
  • Donate, L.E., and Blasco, M.A., 2011. Telomeres in cancer and ageing. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences, 366 (1561), 76–84.
  • Fujita, T., 1999. Senescence marker protein-30 (SMP30): structure and biological function. Biochemical and Biophysical Research Communications, 254 (1), 1–4.
  • Ghosh, K., and Capell, B.C., 2016. The Senescence-associated secretory phenotype: critical effector in skin cancer and aging. Journal of Investigative Dermatology, 136 (11), 2133–2139.
  • Gorbunova, V., and Seluanov, A., 2016. DNA double strand break repair, aging and the chromatin connection. Mutation Research, 788, 2–6.
  • Green, M.R., 2008. Senescence: not just for tumor suppression. Cell, 134 (4), 562–564.
  • Harman, D., 1956. Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology, 11 (3), 298–300.
  • Hiyama, K., et al., 2006. Telomeres and Telomerase in Cancer. European Journal of Cancer, 42 (9), 1197–1203.
  • Johmura, Y., et al., 2014. Necessary and sufficient role for a mitosis skip in senescence induction. Molecular Cell, 55 (1), 73–84.
  • Jones, K.R., et al., 2005. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells. International Journal of Radiation Biology, 81 (6), 445–458.
  • Kapoor, V., and Telford, W.G., 2004. Telomere length measurement by fluorescence in situ hybridization and flow cytometry. Methods in Molecular Biology (Clifton, N.J.), 263 (2), 385–398.
  • Kennedy, A.L., et al., 2010. Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Division, 5 (1), 16–27.
  • Kimura, M., et al., 2010. Measurement of telomere length by the Southern Blot analysis of terminal restriction fragment lengths. Nature Protocols, 5 (9), 1596–1607.
  • Kreiling, J.A., et al., 2011. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell, 10 (2), 292–304.
  • Kuilman, T., et al., 2008. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell, 133 (6), 1019–1031.
  • Lawless, C., et al., 2010. Quantitative assessment of markers for cell senescence. Experimental Gerontology, 45 (10), 772–778.
  • Li, Y., et al., 2013. Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1. Oncology Reports, 29 (5), 1805–1810.
  • Lu, S.Y., et al., 2006. Ripe areca nut extract induces G 1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis, 27 (6), 1273–1284.
  • Lu, Y., et al., 2017. The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence. Scientific Reports, 7, 41390.
  • Masutomi, K., et al., 2005. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proceedings of the National Academy of Sciences of the United States of America, 102 (23), 8222–8227.
  • Matos, L., Gouveia, A., and Almeida, H., 2012. Copper ability to induce premature senescence in human fibroblasts. Age (Dordrecht, Netherlands), 34 (4), 783–794.
  • Mohrin, M., and Chen, D., 2016. The mitochondrial metabolic checkpoint and aging of hematopoietic stem cells. Current Opinion in Hematology, 23 (4), 318–324.
  • Narita, M., et al., 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell, 113 (6), 703–716.
  • Niizuma, S., et al., 2012. Effect of persistent activation of phosphoinositide 3-kinase on heart. Life Sciences, 90 (15–16), 619–628.
  • O'Hagan-Wong, K., et al., 2016. Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis. Oncotarget, 7 (12), 13285–13296.
  • Pal, H.C., et al., 2013. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways. Plos One, 8 (10), e77270
  • Pati, S., et al., 2014. X-gal staining of canine skin tissues: a technique with multiple possible applications. Journal of Natural Science Biology and Medicine, 5 (2), 245–249.
  • Petropoulou, C., et al., 2001. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. Febs Letters, 509 (2), 287–297.
  • Raghuram, G.V., and Mishra, P.K., 2014. Stress induced premature senescence: a new culprit in ovarian tumorigenesis? Indian Journal of Medical Research, 140(Suppl 1), S120–S129.
  • Rodier, F., 2013. Detection of the Senescence-Associated Secretory Phenotype (SASP). Methods in Molecular Biology, 965, 165–173.
  • Sagiv, A., et al., 2013. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene, 32 (15), 1971–1977.
  • Severino, J., et al., 2000. Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Experimental Cell Research, 257 (1), 162–171.
  • Sorrentino, J.A., et al., 2014. p16INK4a reporter mice reveal age-promoting effects of environmental toxicants. Journal of Clinical Investigation, 124 (1), 169–173.
  • Sosińska, P., et al., 2014. Specificity of cytochemical and fluorescence methods of senescence-associated β-galactosidase detection for ageing driven by replication and time. Biogerontology, 15 (4), 407–413.
  • Sun, Q., and Zhang, H.B., 2008. Senescence is a defensive mechasim against oncogene-induced tumorigenesis. Basic and Clinical Medicine, 28 (5), 519–522.
  • Thambisetty, M., et al., 2010. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry, 67 (7), 739–748.
  • Trougakos, I.P., and Gonos, E.S., 2002. Clusterin/Apolipoprotein J in human aging and cancer. International Journal of Biochemistry and Cell Biology, 34 (11), 1430–1448.
  • Vaughan, S., and Jat, P.S., 2011. Deciphering the role of Nuclear Factor-κB in cellular senescence. Aging, 3 (10), 913–919. (
  • Wang, C., et al., 2009. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell, 8 (3), 311–323.
  • Wang, D., et al., 2016. Isolation of live premature senescent cells using FUCCI technology. Scientific Reports, 6, 30705.
  • Yumura, W., et al., 2006. Accelerated tubular cell senescence in SMP30 knockout mice. Histology and Histopathology, 21 (11), 1151–1156.
  • Zhang, S.C., et al., 2014. Inhibition of SMP30 gene expression influences the biological characteristics of human Hep G2 cells. Asian Pacific Journal of Cancer Prevention Apjcp, 15 (3), 1193–1196.
  • Zhong, B., et al., 2010. Induction of clusterin by AKT—role in cytoprotection against docetaxel in prostate tumor cells. Molecular Cancer Therapeutics, 9 (6), 1831–1841.
  • Zhou, J., et al., 2015. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. Scientific Reports, 5, 15085.
  • Zhou, S.F., et al., 2011. Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma. Clinical Biochemistry, 44 (4), 331–336.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.